Cancer metastasis: biologic basis and therapeutics
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY
Cambridge University Press
2011, c2011
|
Schlagworte: | |
Online-Zugang: | TUM01 Volltext |
Beschreibung: | Includes bibliographical references and index Machine generated contents note: Overview Josh Fidler; 1. Introduction to basic research Harold Moses; Part I. Basic Research: 2. Animal models of metastasis Janet Price; 3. Non-traditional models of metastasis including drosophilia Elisa Woodhouse; 4. Computational models of metastasis Wayne Kendal; 5. Metastatic inefficiency and tumor dormancy Ann Chambers; 6. The role of the epithelial-mesenchymal transition (EMT) and MET in metastasis Erik Thompson, Donald Newgreen, and Lilian Soon; 7. Proteolytic pathways in metastasis Johanna Joyce; 8. The role of matrix metalloproteinases in tumor invasion and metastasis Barbara Fingleton; 9. The role of the urokinase system in invasion and metastasis Julio Aguirre-Ghiso; 10. Apoptotic and anoikis mechanisms controlling steps of the metastatic cascade Kounosuke Watabe; 11. Intra-vital video microscopy to visualize invasion and metastasis Erik Sahai; 12. The influence of inflammation and chemokines in metastasis Michael Karin; 13. How aging and cellular senescence influences metastasis Futoshi Okada and Hiroshi Kobayashi; 14. Hematopological vs. lymphatic metastasis: a comparison of tumor cell interactions with vascular vs. lymphatic endothelium Marc Achen, Steven Stacker, and Tara Karezis; 15. The role of microparticles in metastasis Hector Peinado and Bethan Psaila; 16. Endothelial-specific markers that determine organ-specificity of metastasis Renata Pasqualini; 17. Mechanisms of organ selectivity Yibin Kang 18. Growth regulatory pathways that determine organ selectivity of metastasis Suzanne Eccles; 19. The pre-metastatic niche Mariannna Papaspyridonos and Rosandra Kaplan; 20. Metastasis-promoting genes Paul Fisher; 21. Metastasis-suppressor genes Patricia Steeg and Carrie Rinker-Schaeffer; 22. Epigenetic regulation of metastasis Manel Esteller; 23. Host determinants of metastatic potential Nigel Crawford; Part II. Clinical Research: 24. Introduction to clinical section Nancy E. Davidson; 25. Sarcomas Lee Helman and Chand Khanna; 26. Neuroblastoma Nai Kong Cheung; 27. Retinoblastoma David Abramson; 28. Primary brain tumors and cerebral metastases Mitchel Berger; 29. Head and neck Ketayun Dinshaw; 30. Melanomas John Kirkwood; 31. Gastric Yasuhide Yamada; 32. Pancreas Jose; Eduardo Monteiro Cunha; 33. Liver (primary and hepatic metastases) Zhao-you Tang; 34. Colon Andrea Wang-Gillam; 35. Lung Rafael Rosell-Costa; 36. Thyroid Michael Tuttle; 37. Kidney cancer metastasis Jean Jacques; 38. Bladder Dan Theodorescu; 39. Myeloma/ Lymphoma G. David Roodman; 40. Breast metastasis Heather L. McArthur, Clifford A. Hudis, and Patrick Morris; 41. OBGYN S. Diane Yamada; 42. Prostate cancer metastasis Kenneth Pienta; 43. Testicular and germ cell Robert Hromas; 44. Proteomics and molecular markers Lance Liotta; 45. Bone marrow / MRD Klaus Pantel; 46. Sentinel lymph nodes Jeffrey Gershenwald; 47. Molecular imaging and metastasis Lily Wu; 48. Complications of bone metastases including nerve pain Robert E. Coleman; 49. Coagulation Simon Karpatkin and David Green; 50. Nanoparticles P. Charles Lin; 51. Metronomics Robert Kerbel; 52. Therapeutics Paul Elvin; 53. Immunotherapy Pier-Luigi Lollini, Patrizia Nanni and Carla DeGiovanni; 54. Radiotherapy Hak Choy; 55. Regulatory issues surrounding clinical trials of anti-metastatic therapies George W. Sledge, Jr "Metastasis is responsible for a large burden of morbidity and mortality among cancer patients, and currently few therapies specifically target metastatic disease. Further scientific dissection of the underlying pathways is required to pave the way for new therapeutic targets. This groundbreaking new text comprehensively covers the processes underlying cancer metastasis and the clinical treatment of metastatic disease. Whereas previous volumes have been compendia of laboratory research articles, the internationally renowned authors of this volume have summarized the state-of-the-art research in the metastasis field. A major section covers the cellular and molecular pathways of metastasis and experimental techniques and the systems and models applied in this field. Subsequently, the clinical aspects of the major cancer types are considered, focusing on disease-specific research and therapeutic approaches to metastatic disease. The focus is on novel pathophysiological insights and emerging therapies; future directions for research and unmet clinical needs are also discussed"--Provided by publisher |
Beschreibung: | 1 Online-Ressource (xvii, 642 p.) |
ISBN: | 0521887216 1139127063 9780521887212 9781139127066 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV040473519 | ||
003 | DE-604 | ||
005 | 20130723 | ||
007 | cr|uuu---uuuuu | ||
008 | 121011s2011 |||| o||u| ||||||eng d | ||
020 | |a 0521887216 |9 0-521-88721-6 | ||
020 | |a 1139127063 |c electronic bk. |9 1-139-12706-3 | ||
020 | |a 9780521887212 |9 978-0-521-88721-2 | ||
020 | |a 9781139127066 |c electronic bk. |9 978-1-139-12706-6 | ||
035 | |a (OCoLC)874193903 | ||
035 | |a (DE-599)BVBBV040473519 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-91 | ||
245 | 1 | 0 | |a Cancer metastasis |b biologic basis and therapeutics |c edited by David Lyden, Danny R. Welch, Bethan Psaila |
264 | 1 | |a New York, NY |b Cambridge University Press |c 2011, c2011 | |
300 | |a 1 Online-Ressource (xvii, 642 p.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a Machine generated contents note: Overview Josh Fidler; 1. Introduction to basic research Harold Moses; Part I. Basic Research: 2. Animal models of metastasis Janet Price; 3. Non-traditional models of metastasis including drosophilia Elisa Woodhouse; 4. Computational models of metastasis Wayne Kendal; 5. Metastatic inefficiency and tumor dormancy Ann Chambers; 6. The role of the epithelial-mesenchymal transition (EMT) and MET in metastasis Erik Thompson, Donald Newgreen, and Lilian Soon; 7. Proteolytic pathways in metastasis Johanna Joyce; 8. The role of matrix metalloproteinases in tumor invasion and metastasis Barbara Fingleton; 9. The role of the urokinase system in invasion and metastasis Julio Aguirre-Ghiso; 10. Apoptotic and anoikis mechanisms controlling steps of the metastatic cascade Kounosuke Watabe; 11. Intra-vital video microscopy to visualize invasion and metastasis Erik Sahai; 12. The influence of inflammation and chemokines in metastasis Michael Karin; 13. How aging and cellular senescence influences metastasis Futoshi Okada and Hiroshi Kobayashi; 14. Hematopological vs. lymphatic metastasis: a comparison of tumor cell interactions with vascular vs. lymphatic endothelium Marc Achen, Steven Stacker, and Tara Karezis; 15. The role of microparticles in metastasis Hector Peinado and Bethan Psaila; 16. Endothelial-specific markers that determine organ-specificity of metastasis Renata Pasqualini; 17. Mechanisms of organ selectivity Yibin Kang | ||
500 | |a 18. Growth regulatory pathways that determine organ selectivity of metastasis Suzanne Eccles; 19. The pre-metastatic niche Mariannna Papaspyridonos and Rosandra Kaplan; 20. Metastasis-promoting genes Paul Fisher; 21. Metastasis-suppressor genes Patricia Steeg and Carrie Rinker-Schaeffer; 22. Epigenetic regulation of metastasis Manel Esteller; 23. Host determinants of metastatic potential Nigel Crawford; Part II. Clinical Research: 24. Introduction to clinical section Nancy E. Davidson; 25. Sarcomas Lee Helman and Chand Khanna; 26. Neuroblastoma Nai Kong Cheung; 27. Retinoblastoma David Abramson; 28. Primary brain tumors and cerebral metastases Mitchel Berger; 29. Head and neck Ketayun Dinshaw; 30. Melanomas John Kirkwood; 31. Gastric Yasuhide Yamada; 32. Pancreas Jose; Eduardo Monteiro Cunha; 33. Liver (primary and hepatic metastases) Zhao-you Tang; 34. Colon Andrea Wang-Gillam; 35. Lung Rafael Rosell-Costa; 36. Thyroid Michael Tuttle; 37. Kidney cancer metastasis Jean Jacques; 38. Bladder Dan Theodorescu; 39. Myeloma/ Lymphoma G. David Roodman; 40. Breast metastasis Heather L. McArthur, Clifford A. Hudis, and Patrick Morris; 41. OBGYN S. Diane Yamada; 42. Prostate cancer metastasis Kenneth Pienta; 43. Testicular and germ cell Robert Hromas; 44. Proteomics and molecular markers Lance Liotta; 45. Bone marrow / MRD Klaus Pantel; 46. Sentinel lymph nodes Jeffrey Gershenwald; 47. Molecular imaging and metastasis Lily Wu; 48. Complications of bone metastases including nerve pain Robert E. Coleman; 49. Coagulation Simon Karpatkin and David Green; 50. Nanoparticles P. Charles Lin; 51. Metronomics Robert Kerbel; 52. Therapeutics Paul Elvin; 53. Immunotherapy Pier-Luigi Lollini, Patrizia Nanni and Carla DeGiovanni; 54. Radiotherapy Hak Choy; 55. Regulatory issues surrounding clinical trials of anti-metastatic therapies George W. Sledge, Jr | ||
500 | |a "Metastasis is responsible for a large burden of morbidity and mortality among cancer patients, and currently few therapies specifically target metastatic disease. Further scientific dissection of the underlying pathways is required to pave the way for new therapeutic targets. This groundbreaking new text comprehensively covers the processes underlying cancer metastasis and the clinical treatment of metastatic disease. Whereas previous volumes have been compendia of laboratory research articles, the internationally renowned authors of this volume have summarized the state-of-the-art research in the metastasis field. A major section covers the cellular and molecular pathways of metastasis and experimental techniques and the systems and models applied in this field. Subsequently, the clinical aspects of the major cancer types are considered, focusing on disease-specific research and therapeutic approaches to metastatic disease. The focus is on novel pathophysiological insights and emerging therapies; future directions for research and unmet clinical needs are also discussed"--Provided by publisher | ||
650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
650 | 4 | |a Medizin | |
650 | 4 | |a Metastasis | |
650 | 4 | |a Neoplasm Metastasis / physiopathology | |
650 | 4 | |a Neoplasm Metastasis / therapy | |
650 | 4 | |a HEALTH & FITNESS / Diseases / Cancer / bisacsh | |
650 | 4 | |a MEDICAL / Oncology / bisacsh | |
700 | 1 | |a Lyden, David |d 1959- |e Sonstige |0 (DE-588)1014625769 |4 oth | |
700 | 1 | |a Welch, Danny R. |e Sonstige |4 oth | |
700 | 1 | |a Psaila, Bethan |d 1979- |e Sonstige |0 (DE-588)1014625815 |4 oth | |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=399307 |x Verlag |3 Volltext |
912 | |a ZDB-4-NLEBK | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-025320808 | ||
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=399307 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCO_MED_gekauft |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804149536795394048 |
---|---|
any_adam_object | |
author_GND | (DE-588)1014625769 (DE-588)1014625815 |
building | Verbundindex |
bvnumber | BV040473519 |
collection | ZDB-4-NLEBK |
ctrlnum | (OCoLC)874193903 (DE-599)BVBBV040473519 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06365nmm a2200493zc 4500</leader><controlfield tag="001">BV040473519</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130723 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">121011s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0521887216</subfield><subfield code="9">0-521-88721-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1139127063</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-139-12706-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780521887212</subfield><subfield code="9">978-0-521-88721-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139127066</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-139-12706-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)874193903</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040473519</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer metastasis</subfield><subfield code="b">biologic basis and therapeutics</subfield><subfield code="c">edited by David Lyden, Danny R. Welch, Bethan Psaila</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2011, c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 642 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Machine generated contents note: Overview Josh Fidler; 1. Introduction to basic research Harold Moses; Part I. Basic Research: 2. Animal models of metastasis Janet Price; 3. Non-traditional models of metastasis including drosophilia Elisa Woodhouse; 4. Computational models of metastasis Wayne Kendal; 5. Metastatic inefficiency and tumor dormancy Ann Chambers; 6. The role of the epithelial-mesenchymal transition (EMT) and MET in metastasis Erik Thompson, Donald Newgreen, and Lilian Soon; 7. Proteolytic pathways in metastasis Johanna Joyce; 8. The role of matrix metalloproteinases in tumor invasion and metastasis Barbara Fingleton; 9. The role of the urokinase system in invasion and metastasis Julio Aguirre-Ghiso; 10. Apoptotic and anoikis mechanisms controlling steps of the metastatic cascade Kounosuke Watabe; 11. Intra-vital video microscopy to visualize invasion and metastasis Erik Sahai; 12. The influence of inflammation and chemokines in metastasis Michael Karin; 13. How aging and cellular senescence influences metastasis Futoshi Okada and Hiroshi Kobayashi; 14. Hematopological vs. lymphatic metastasis: a comparison of tumor cell interactions with vascular vs. lymphatic endothelium Marc Achen, Steven Stacker, and Tara Karezis; 15. The role of microparticles in metastasis Hector Peinado and Bethan Psaila; 16. Endothelial-specific markers that determine organ-specificity of metastasis Renata Pasqualini; 17. Mechanisms of organ selectivity Yibin Kang</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">18. Growth regulatory pathways that determine organ selectivity of metastasis Suzanne Eccles; 19. The pre-metastatic niche Mariannna Papaspyridonos and Rosandra Kaplan; 20. Metastasis-promoting genes Paul Fisher; 21. Metastasis-suppressor genes Patricia Steeg and Carrie Rinker-Schaeffer; 22. Epigenetic regulation of metastasis Manel Esteller; 23. Host determinants of metastatic potential Nigel Crawford; Part II. Clinical Research: 24. Introduction to clinical section Nancy E. Davidson; 25. Sarcomas Lee Helman and Chand Khanna; 26. Neuroblastoma Nai Kong Cheung; 27. Retinoblastoma David Abramson; 28. Primary brain tumors and cerebral metastases Mitchel Berger; 29. Head and neck Ketayun Dinshaw; 30. Melanomas John Kirkwood; 31. Gastric Yasuhide Yamada; 32. Pancreas Jose; Eduardo Monteiro Cunha; 33. Liver (primary and hepatic metastases) Zhao-you Tang; 34. Colon Andrea Wang-Gillam; 35. Lung Rafael Rosell-Costa; 36. Thyroid Michael Tuttle; 37. Kidney cancer metastasis Jean Jacques; 38. Bladder Dan Theodorescu; 39. Myeloma/ Lymphoma G. David Roodman; 40. Breast metastasis Heather L. McArthur, Clifford A. Hudis, and Patrick Morris; 41. OBGYN S. Diane Yamada; 42. Prostate cancer metastasis Kenneth Pienta; 43. Testicular and germ cell Robert Hromas; 44. Proteomics and molecular markers Lance Liotta; 45. Bone marrow / MRD Klaus Pantel; 46. Sentinel lymph nodes Jeffrey Gershenwald; 47. Molecular imaging and metastasis Lily Wu; 48. Complications of bone metastases including nerve pain Robert E. Coleman; 49. Coagulation Simon Karpatkin and David Green; 50. Nanoparticles P. Charles Lin; 51. Metronomics Robert Kerbel; 52. Therapeutics Paul Elvin; 53. Immunotherapy Pier-Luigi Lollini, Patrizia Nanni and Carla DeGiovanni; 54. Radiotherapy Hak Choy; 55. Regulatory issues surrounding clinical trials of anti-metastatic therapies George W. Sledge, Jr</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Metastasis is responsible for a large burden of morbidity and mortality among cancer patients, and currently few therapies specifically target metastatic disease. Further scientific dissection of the underlying pathways is required to pave the way for new therapeutic targets. This groundbreaking new text comprehensively covers the processes underlying cancer metastasis and the clinical treatment of metastatic disease. Whereas previous volumes have been compendia of laboratory research articles, the internationally renowned authors of this volume have summarized the state-of-the-art research in the metastasis field. A major section covers the cellular and molecular pathways of metastasis and experimental techniques and the systems and models applied in this field. Subsequently, the clinical aspects of the major cancer types are considered, focusing on disease-specific research and therapeutic approaches to metastatic disease. The focus is on novel pathophysiological insights and emerging therapies; future directions for research and unmet clinical needs are also discussed"--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metastasis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasm Metastasis / physiopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasm Metastasis / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer / bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MEDICAL / Oncology / bisacsh</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lyden, David</subfield><subfield code="d">1959-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1014625769</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Welch, Danny R.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Psaila, Bethan</subfield><subfield code="d">1979-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1014625815</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=399307</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025320808</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=399307</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCO_MED_gekauft</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV040473519 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T00:24:36Z |
institution | BVB |
isbn | 0521887216 1139127063 9780521887212 9781139127066 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025320808 |
oclc_num | 874193903 |
open_access_boolean | |
owner | DE-91 DE-BY-TUM |
owner_facet | DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (xvii, 642 p.) |
psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCO_MED_gekauft |
publishDate | 2011 |
publishDateSearch | 2011 |
publishDateSort | 2011 |
publisher | Cambridge University Press |
record_format | marc |
spelling | Cancer metastasis biologic basis and therapeutics edited by David Lyden, Danny R. Welch, Bethan Psaila New York, NY Cambridge University Press 2011, c2011 1 Online-Ressource (xvii, 642 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Machine generated contents note: Overview Josh Fidler; 1. Introduction to basic research Harold Moses; Part I. Basic Research: 2. Animal models of metastasis Janet Price; 3. Non-traditional models of metastasis including drosophilia Elisa Woodhouse; 4. Computational models of metastasis Wayne Kendal; 5. Metastatic inefficiency and tumor dormancy Ann Chambers; 6. The role of the epithelial-mesenchymal transition (EMT) and MET in metastasis Erik Thompson, Donald Newgreen, and Lilian Soon; 7. Proteolytic pathways in metastasis Johanna Joyce; 8. The role of matrix metalloproteinases in tumor invasion and metastasis Barbara Fingleton; 9. The role of the urokinase system in invasion and metastasis Julio Aguirre-Ghiso; 10. Apoptotic and anoikis mechanisms controlling steps of the metastatic cascade Kounosuke Watabe; 11. Intra-vital video microscopy to visualize invasion and metastasis Erik Sahai; 12. The influence of inflammation and chemokines in metastasis Michael Karin; 13. How aging and cellular senescence influences metastasis Futoshi Okada and Hiroshi Kobayashi; 14. Hematopological vs. lymphatic metastasis: a comparison of tumor cell interactions with vascular vs. lymphatic endothelium Marc Achen, Steven Stacker, and Tara Karezis; 15. The role of microparticles in metastasis Hector Peinado and Bethan Psaila; 16. Endothelial-specific markers that determine organ-specificity of metastasis Renata Pasqualini; 17. Mechanisms of organ selectivity Yibin Kang 18. Growth regulatory pathways that determine organ selectivity of metastasis Suzanne Eccles; 19. The pre-metastatic niche Mariannna Papaspyridonos and Rosandra Kaplan; 20. Metastasis-promoting genes Paul Fisher; 21. Metastasis-suppressor genes Patricia Steeg and Carrie Rinker-Schaeffer; 22. Epigenetic regulation of metastasis Manel Esteller; 23. Host determinants of metastatic potential Nigel Crawford; Part II. Clinical Research: 24. Introduction to clinical section Nancy E. Davidson; 25. Sarcomas Lee Helman and Chand Khanna; 26. Neuroblastoma Nai Kong Cheung; 27. Retinoblastoma David Abramson; 28. Primary brain tumors and cerebral metastases Mitchel Berger; 29. Head and neck Ketayun Dinshaw; 30. Melanomas John Kirkwood; 31. Gastric Yasuhide Yamada; 32. Pancreas Jose; Eduardo Monteiro Cunha; 33. Liver (primary and hepatic metastases) Zhao-you Tang; 34. Colon Andrea Wang-Gillam; 35. Lung Rafael Rosell-Costa; 36. Thyroid Michael Tuttle; 37. Kidney cancer metastasis Jean Jacques; 38. Bladder Dan Theodorescu; 39. Myeloma/ Lymphoma G. David Roodman; 40. Breast metastasis Heather L. McArthur, Clifford A. Hudis, and Patrick Morris; 41. OBGYN S. Diane Yamada; 42. Prostate cancer metastasis Kenneth Pienta; 43. Testicular and germ cell Robert Hromas; 44. Proteomics and molecular markers Lance Liotta; 45. Bone marrow / MRD Klaus Pantel; 46. Sentinel lymph nodes Jeffrey Gershenwald; 47. Molecular imaging and metastasis Lily Wu; 48. Complications of bone metastases including nerve pain Robert E. Coleman; 49. Coagulation Simon Karpatkin and David Green; 50. Nanoparticles P. Charles Lin; 51. Metronomics Robert Kerbel; 52. Therapeutics Paul Elvin; 53. Immunotherapy Pier-Luigi Lollini, Patrizia Nanni and Carla DeGiovanni; 54. Radiotherapy Hak Choy; 55. Regulatory issues surrounding clinical trials of anti-metastatic therapies George W. Sledge, Jr "Metastasis is responsible for a large burden of morbidity and mortality among cancer patients, and currently few therapies specifically target metastatic disease. Further scientific dissection of the underlying pathways is required to pave the way for new therapeutic targets. This groundbreaking new text comprehensively covers the processes underlying cancer metastasis and the clinical treatment of metastatic disease. Whereas previous volumes have been compendia of laboratory research articles, the internationally renowned authors of this volume have summarized the state-of-the-art research in the metastasis field. A major section covers the cellular and molecular pathways of metastasis and experimental techniques and the systems and models applied in this field. Subsequently, the clinical aspects of the major cancer types are considered, focusing on disease-specific research and therapeutic approaches to metastatic disease. The focus is on novel pathophysiological insights and emerging therapies; future directions for research and unmet clinical needs are also discussed"--Provided by publisher HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Medizin Metastasis Neoplasm Metastasis / physiopathology Neoplasm Metastasis / therapy HEALTH & FITNESS / Diseases / Cancer / bisacsh MEDICAL / Oncology / bisacsh Lyden, David 1959- Sonstige (DE-588)1014625769 oth Welch, Danny R. Sonstige oth Psaila, Bethan 1979- Sonstige (DE-588)1014625815 oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=399307 Verlag Volltext |
spellingShingle | Cancer metastasis biologic basis and therapeutics HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Medizin Metastasis Neoplasm Metastasis / physiopathology Neoplasm Metastasis / therapy HEALTH & FITNESS / Diseases / Cancer / bisacsh MEDICAL / Oncology / bisacsh |
title | Cancer metastasis biologic basis and therapeutics |
title_auth | Cancer metastasis biologic basis and therapeutics |
title_exact_search | Cancer metastasis biologic basis and therapeutics |
title_full | Cancer metastasis biologic basis and therapeutics edited by David Lyden, Danny R. Welch, Bethan Psaila |
title_fullStr | Cancer metastasis biologic basis and therapeutics edited by David Lyden, Danny R. Welch, Bethan Psaila |
title_full_unstemmed | Cancer metastasis biologic basis and therapeutics edited by David Lyden, Danny R. Welch, Bethan Psaila |
title_short | Cancer metastasis |
title_sort | cancer metastasis biologic basis and therapeutics |
title_sub | biologic basis and therapeutics |
topic | HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Medizin Metastasis Neoplasm Metastasis / physiopathology Neoplasm Metastasis / therapy HEALTH & FITNESS / Diseases / Cancer / bisacsh MEDICAL / Oncology / bisacsh |
topic_facet | HEALTH & FITNESS / Diseases / Cancer MEDICAL / Oncology Medizin Metastasis Neoplasm Metastasis / physiopathology Neoplasm Metastasis / therapy HEALTH & FITNESS / Diseases / Cancer / bisacsh MEDICAL / Oncology / bisacsh |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=399307 |
work_keys_str_mv | AT lydendavid cancermetastasisbiologicbasisandtherapeutics AT welchdannyr cancermetastasisbiologicbasisandtherapeutics AT psailabethan cancermetastasisbiologicbasisandtherapeutics |